Stephen Hill
Chief Operating Officer en LYELL IMMUNOPHARMA, INC. .
Fortuna: 19 909 $ al 31/03/2024
Perfil
Stephen Hill is currently the Chief Operating Officer at Lyell Immunopharma, Inc. He previously worked as the Vice President-Bulk Manufacturing at Amgen, Inc. and as the SVP & Head-Global Biologics Operations at AstraZeneca PLC.
Mr. Hill received his undergraduate degree and MBA from the University of Washington.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC.
0.00% | 09/02/2024 | 8 928 ( 0.00% ) | 19 909 $ | 31/03/2024 |
Cargos activos de Stephen Hill
| Empresas | Cargo | Inicio |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Operating Officer | 01/11/2021 |
Antiguos cargos conocidos de Stephen Hill.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2019 |
| AMGEN INC. | Corporate Officer/Principal | - |
Formación de Stephen Hill.
| University of Washington | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Hill
